Skip to Content
You are currently on the new version of our website. Access the old version .
  • Advances in Respiratory Medicine is published by MDPI from Volume 90 Issue 4 (2022). Previous articles were published by another publisher in Open Access under a CC-BY (or CC-BY-NC-ND) licence, and they are hosted by MDPI on mdpi.com as a courtesy and upon agreement with Via Medica.
  • Article
  • Open Access

8 September 2006

Serum and Sputum Eosinophil Cationic Protein Levels and Clinical Status in Cystic Fibrosis Patients

,
,
,
and
1
Oddział Kliniczny Interny Dziecięcej i Alergologii III Katedry Pediatrii UM w Łodzi, Pabianicka 62, 93-513 Łódź, Poland
2
Uniwersytet Medyczny w Łodzi, Łódź, Poland
*
Author to whom correspondence should be addressed.

Abstract

Recent studies have emphasied the role of eosinophils and it’s metabolites in the pathogenesis of lung disease in cystic fi brosis. This study was designed to assess the relationship between serum and sputum ECP levels and clinical status of cystic fi brosis patients. Material and methods: 30 patients, aged 6–30 with moderate cystic fi brosis were recruited. Spirometry, weight and high, and Shwachman-Kulczycki score were measured, and serum and sputum samples were obtained for measure-ments of the eosinophil cationic protein (ECP). Results: We observed signifi cant inverse correlation between sputum ECP levels and BMI (p < 0.001) and FEV1 (p < 0.001), and not signifi cant inverse correlation between sputum ECP levels Shwachman-Kulczycki score (p = 0.057). There was no signifi cant correlation between sputum ECP levels and FEF25/75% and between serum ECP levels and measured clinical parameters. Conclusions: Results of this study suggest infl uence of eosinophil infl ammation in respiratory tract on clinical status of CF patients.

Article Metrics

Citations

Article Access Statistics

Multiple requests from the same IP address are counted as one view.